Comparison of Clinical, Laboratory and Demographic Characteristics of Patients Diagnosed with COVID-19 as Symptomatic and Atypical Symptoms

Basit Öğe Kaydı
dc.authoridDemir, Mehmet Cihat/0000-0002-0106-3383
dc.authorwosidDemir, Mehmet Cihat/A-9087-2017
dc.contributor.authorAkpinar, Guleser
dc.contributor.authorDemir, Mehmet C.
dc.contributor.authorSultanoglu, Hasan
dc.contributor.authorUnlu, Elif N.
dc.contributor.authorOksuz, Sukru
dc.date.accessioned2021-12-01T18:47:11Z
dc.date.available2021-12-01T18:47:11Z
dc.date.issued2021
dc.department[Belirlenecek]en_US
dc.description.abstractBackground: Clinical findings of COVID-19 have been observed with a wide spectrum ranging from asymptomatic disease and mild upper respiratory tract infection to severe viral pneumonia resulting in mortality. While clinical symptoms present in some COVID-19 patients, others have been incidentally identified. The objective of this study was to examine the clinical and laboratory features of patients diagnosed with COVID-19 who were symptomatic or had atypical symptoms and to make a contribution to the literature. Methods: Patients with the likelihood of having COVID-19 pneumonia were evaluated with RT-PCR samples, other laboratory tests, and chest computed tomography. Results: There were significant differences between these groups in terms of age, dyspnea, saturation, and comor-bidities including hypertension [HT] in 19 patients, cerebrovascular events [CVE] that were classified as other diseases in two patients (intracranial mass in one patient and Alzheimer's disease in one patient), and CRP and platelet counts (PLT) among the laboratory parameters (for all p < 0.05). Conclusions: Atypical symptoms have increased due to the progression of the outbreak. Infected people with atypical symptoms can act as sources of the infection. Therefore, the epidemiological history of these patients should be sought in detail, and individuals with atypical symptoms in society should be identified as soon as possible in order to control the spreading of the disease.en_US
dc.identifier.doi10.7754/Clin.Lab.2020.200929
dc.identifier.endpage1272en_US
dc.identifier.issn1433-6510
dc.identifier.issue5en_US
dc.identifier.pmid33978366en_US
dc.identifier.scopus2-s2.0-85105768781en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage1266en_US
dc.identifier.urihttps://doi.org/10.7754/Clin.Lab.2020.200929
dc.identifier.urihttps://hdl.handle.net/20.500.12684/10181
dc.identifier.volume67en_US
dc.identifier.wosWOS:000652161500022en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherClin Lab Publen_US
dc.relation.ispartofClinical Laboratoryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCOVID-19en_US
dc.subjectatypical symptomen_US
dc.subjectemergency medicineen_US
dc.titleComparison of Clinical, Laboratory and Demographic Characteristics of Patients Diagnosed with COVID-19 as Symptomatic and Atypical Symptomsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu